Search
+
    SEARCHED FOR:

    KEY CORP LTD Q4 RESULTS

    Accenture quarterly numbers point to strong GenAI prospects

    Accenture's latest earnings boost Indian IT sector outlook. GenAI bookings hit a record high. North American demand shows signs of recovery. The company raised its FY25 growth forecast. Indian IT firms expect strong Q3 results and a robust FY26. Accenture's hiring continues to grow, mostly in India.

    Bank of Baroda shares in focus as lender to raise Rs 10,000 crore via long-term bonds

    Shares of state-owned Bank of Baroda (BoB) will be in focus on Thursday after the bank’s board approved raising up to Rs 10,000 crore through long-term bonds. The funds will be used to finance infrastructure and affordable housing projects.

    RITES shares rally over 4% after securing Rs 148.25 crore order from IIM Raipur

    RITES shares rose 4.4% after securing a Rs 148.25 crore order from IIM Raipur for campus development. Despite lower Q2 profits, the company has seen over 18% gains this year.

    Average Swiggy order value can show double-digit growth every year; no plan to raise fresh funds: Rahul Bothra

    Swiggy, with a healthy cash balance of over ₹8,000 crore, has no immediate fundraising plans. Their food delivery business is profitable and generating cash, while the quick commerce segment is projected to achieve profitability within six to seven quarters. They aim to double their dark store footprint by March 2025 and increase average order value at a double-digit pace annually.

    Macy's shares drop 3.5% after it delays quarterly results on finding employee hid millions in delivery expenses

    Macy's delayed its third-quarter results after uncovering an employee's concealment of $132 million to $154 million in delivery expenses. Preliminary sales figures missed Wall Street expectations, and the company's stock dipped. An internal investigation is underway, with full results and a revised outlook expected by December 11. Despite this, Macy's CEO expressed optimism about the upcoming holiday season.

    India's pharma sector registers strong Q2 FY25 growth, driven by North America market: Report

    The major pharmaceutical companies of the country reported a 10 per cent year-on-year (YoY) growth in the second quarter of FY25, largely driven by strong performance in North America and the domestic market, according to a report by Axis Securities.

    The Economic Times
    BACK TO TOP
      翻译: